We read with interest the recent paper by Munsksgaard et al in which they found no differences in the levels of nociceptin and CGRP between controls and patients with medication-overuse… Click to show full abstract
We read with interest the recent paper by Munsksgaard et al in which they found no differences in the levels of nociceptin and CGRP between controls and patients with medication-overuse headache (MOH).1 As the authors point out in their conclusions, and we will focus here on CGRP levels, these results contrast to previous findings.2.
               
Click one of the above tabs to view related content.